Insights into the treatment burden of hereditary angioedema in the evolving treatment landscape.
Publication
, Journal Article
Banerji, A; Riedl, MA; Craig, TJ; Radojicic, C
Published in: Allergy Asthma Proc
May 1, 2021
Duke Scholars
Published In
Allergy Asthma Proc
DOI
EISSN
1539-6304
Publication Date
May 1, 2021
Volume
42
Issue
3
Start / End Page
S1 / S3
Location
United States
Related Subject Headings
- Humans
- Complement C1 Inhibitor Protein
- Angioedemas, Hereditary
- 3204 Immunology
- 1107 Immunology
Citation
APA
Chicago
ICMJE
MLA
NLM
Banerji, A., Riedl, M. A., Craig, T. J., & Radojicic, C. (2021). Insights into the treatment burden of hereditary angioedema in the evolving treatment landscape. Allergy Asthma Proc, 42(3), S1–S3. https://doi.org/10.2500/aap.2021.42.210018
Banerji, Aleena, Marc A. Riedl, Timothy J. Craig, and Cristine Radojicic. “Insights into the treatment burden of hereditary angioedema in the evolving treatment landscape.” Allergy Asthma Proc 42, no. 3 (May 1, 2021): S1–3. https://doi.org/10.2500/aap.2021.42.210018.
Banerji A, Riedl MA, Craig TJ, Radojicic C. Insights into the treatment burden of hereditary angioedema in the evolving treatment landscape. Allergy Asthma Proc. 2021 May 1;42(3):S1–3.
Banerji, Aleena, et al. “Insights into the treatment burden of hereditary angioedema in the evolving treatment landscape.” Allergy Asthma Proc, vol. 42, no. 3, May 2021, pp. S1–3. Pubmed, doi:10.2500/aap.2021.42.210018.
Banerji A, Riedl MA, Craig TJ, Radojicic C. Insights into the treatment burden of hereditary angioedema in the evolving treatment landscape. Allergy Asthma Proc. 2021 May 1;42(3):S1–S3.
Published In
Allergy Asthma Proc
DOI
EISSN
1539-6304
Publication Date
May 1, 2021
Volume
42
Issue
3
Start / End Page
S1 / S3
Location
United States
Related Subject Headings
- Humans
- Complement C1 Inhibitor Protein
- Angioedemas, Hereditary
- 3204 Immunology
- 1107 Immunology